Ki-67 Index and Somatostatin Receptor Expression as Prognostic Markers in Patients with Pancreatic Neuroendocrine Tumours: A Review. AGDD [Internet]. 2025 Jul. 17 [cited 2026 Oct. 31];8(1):5-9. Available from: https://somatopub.com/index.php/AGDD/article/view/302